66
Views
61
CrossRef citations to date
0
Altmetric
Research Article

Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation

Pages 505-512 | Published online: 03 Jul 2009
 

Abstract

Purpose: Reoxygenation of a murine tumour after irradiation with carbon ions was investigated and compared to that after gamma-rays. Materials and methods: NFSa fibrosarcoma cells were transplanted into the right hind legs of syngeneic C3H male mice. Conditioning irradiation with either 290MeV/u carbon ions or 137-Cs gamma -rays was delivered to the tumours at 8mm diameter. At given times after irradiation the leg tumours, either clamped or not, received test doses of photons. Diff erences in tumour growth delay between the clamped and non-clamped tumours were interpreted in terms of reoxygenation. A lung-colony assay was used to obtain cell-survival curves. Results: The oxygen enhancement ratio in the NFSa tumour for 74keV mum1 carbon ions was 1.6 while that for gamma-rays was 3.4. The NFSa tumours reoxygenated 4 days after 30Gy of gamma-ray irradiation, but reoxygenated as early as 1 day after 16Gy of carbon ions. Reoxygenation after gamma-rays shortened to 1 day when the tumours were initially clamped for the conditioning irradiation. Conclusions: The fraction of surviving oxic cells in the NFSa tumours is larger after irradiation with carbon ions than with gamma-rays, resulting in accelerated reoxygenation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.